Telemus Capital, LLC Aquestive Therapeutics, Inc. Put Options Transaction History
Telemus Capital, LLC
- $1.2 Billion
- Q4 2023
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AQST
# of Institutions
167Shares Held
66MCall Options Held
794KPut Options Held
457K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$52.9 Million100.0% of portfolio
-
Rtw Investments, LP New York, NY6.25MShares$33.7 Million0.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.66MShares$30.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$29.4 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.76MShares$20.3 Million0.05% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $288M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...